Research Article
EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
Table 2
Correlation analysis between EGFR-AS1 and immune pathways in bladder cancer.
| IncRNA symbol | Immune pathway/cell | value | Marker gene number |
| EGFR-AS1 | TCR signaling pathway | 0.002 | 20 | EGFR-AS1 | Cytokine receptors | 0.006 | 66 | EGFR-AS1 | BCR signaling pathway | 0.06 | 11 | EGFR-AS1 | Antigen processing and presentation | 0.079 | 25 | EGFR-AS1 | Interleukin receptor | 0.079 | 19 | EGFR-AS1 | Natural killer cell cytotoxicity | 0.092 | 14 | EGFR-AS1 | CD8_Tcell | 0.025 | / | EGFR-AS1 | Neutrophil | 0.136 | / | EGFR-AS1 | Dendritic | 0.135 | / | EGFR-AS1 | B_cell | 0.359 | / | EGFR-AS1 | CD4_Tcell | 0.409 | / | EGFR-AS1 | Macrophage | 0.855 | / |
|
|
values < 0.05 were considered statistically significant. |